1 Tiger Global Johnson & Johnson Trades
Tiger Global's position in Johnson & Johnson is currently worth $97.6 Million. That's 0.40% of their equity portfolio (31st largest holding). Tiger Global acquired their 633 Thousand shares in Q1 2009. So far they never sold any shares in the company. The stake costed the investor $34.6 Million, netting the investor a gain of 182% so far.
News about Johnson & Johnson and Tiger Global
Johnson & Johnson tops Wall Street expectations in Q1
Johnson & Johnson (JNJ) reported stronger-than-expected earnings. Goldman Sachs Global Investment Research head of the healthcare business unit Asad Haider j...
Global Irritable Bowel Disease (IBD) Market Research Report 2024: Corticosteroids, JAK inhibitors, TNF inhibitors, Other Drug Classes Insights and Forecast 2019-2029
Johnson & Johnson submits supplemental Biologics License Application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis
Submission is supported by data from the Phase 3 QUASAR program, which showed a significantly greater percentage of patients with moderately to severely acti...
Global Orphan Drugs Market Research Report 2023: Market to Reach $415.2 Billion by the End of 2028 - Premium Pricing of Orphan Drugs and Increasing Collaborations/Licensing Agreements Bolsters Growth